SBC Medical Group Holdings Incorporated (SBC) Current Ratio
- Current ratio · latest quarter: Value 3.31×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 3.31× | Current assets / current liabilities. $259.39M ÷ $78.46M ≈ 3.31× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 259.39M USD | Assets, Current |
| Current obligations | 78.46M USD | Liabilities, Current |
| Cash and equivalents | 184.31M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | (m) | |
| Inventory | 2.98M USD | Inventory, Net |
| Payables | (m) | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $259.39M | $78.46M | $184.31M | (m) | (m) | $2.98M | (m) | (m) | 3.31× |
| 2026-03-31 | $238.78M | $62.57M | $167.31M | (m) | (m) | $2.32M | (m) | (m) | 3.82× |
| 2025-12-31 | $231.22M | $61.12M | $163.77M | (m) | (m) | $2.79M | (m) | (m) | 3.78× |
| 2025-09-30 | $227.20M | $44.58M | $127.43M | (m) | (m) | $1.68M | (m) | (m) | 5.10× |
| 2025-06-30 | $241.34M | $60.68M | $152.74M | (m) | (m) | $1.71M | (m) | (m) | 3.98× |
| 2025-03-31 | $215.10M | $48.47M | $132.06M | (m) | (m) | $1.69M | (m) | (m) | 4.44× |
| 2024-12-31 | $184.45M | $61.19M | $125.04M | (m) | (m) | $1.49M | (m) | (m) | 3.01× |
| 2024-09-30 | $202.10M | $72.42M | $137.39M | (m) | (m) | $1.99M | $14.87M | (m) | 2.79× |
| 2024-06-30 | $1.44M | $4.48M | (m) | (m) | (m) | (m) | $76.99K | (m) | 0.32× |
| 2024-03-31 | $1.77M | $4.40M | (m) | (m) | (m) | (m) | $59.95K | (m) | 0.40× |
| 2023-12-31 | $165.91M | $92.45M | $103.02M | (m) | (m) | $3.09M | (m) | (m) | 1.79× |
| 2023-09-30 | $743.95K | $2.45M | (m) | (m) | (m) | (m) | $34.26K | (m) | 0.30× |
| 2023-06-30 | $1.15M | $2.49M | (m) | (m) | (m) | (m) | $79.85K | (m) | 0.46× |
| 2023-03-31 | $467.69K | $837.05K | (m) | (m) | (m) | (m) | $76.61K | (m) | 0.56× |
| 2022-12-31 | $722.19K | $566.01K | (m) | (m) | (m) | (m) | $79.44K | (m) | 1.28× |
| 2022-09-30 | $844.95K | $260.46K | $579.97K | (m) | (m) | (m) | $76.06K | (m) | 3.24× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |